Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA

International Journal of Stroke

Volumn 4, Issue 4, 2009, Pages 236-

  Ghandehari, Kavian ^a   Pour Zahed, A ^a   Taheri, M ^a   Abbasi, M ^a   Gorjestani, S ^a   Moghaddam Ahmadi, A ^a   Nahayati, M A ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; DEVELOPING COUNTRY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; IRAN; LABORATORY TEST; PRIORITY JOURNAL; PRIVATE HOSPITAL; TERTIARY HEALTH CARE;

EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; IRAN; MALE; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 69149100527     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00273.x     Document Type: Article

References (4)

1. Pandian JD, Padma V, Pamidimukkala V et al. Stroke and thrombolysis in the developing countries. Int J Stroke 2007; 2: 17-26.
2. Suwanwela NC, Phanthumchinda K, Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation. Clin Neurol Neurosurg 2006; 108: 549-52.
3. Pandian JD, Sethi V, Dhillon R et al. Is intravenous thrombolysis feasible in a developing country? Cerebrovasc Dis 2005; 20: 134-6.
4. Padma MV, Singh MB, Bhatia R et al. Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: Efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India 2007; 55: 46-9.